2023–September 2026
2023–2026: repeated attempts to revive gene-editing career despite continuing ethical opposition
He continued to promote gene therapy projects and seek a new institutional base, while remaining a central case in ethical debates concerning germline editing. In 2025, bioethicists explicitly discussed the risks of giving him another scientific platform; he stated that he intended to continue his research despite practical restrictions.
- State of the evidence
- Documented
- Attribution
- Directly implicated
Sources · 2
- [1]Asian Bioethics Review / PMCHe is Back—The Ethics of a Spotlight on a Past Rogue ScientistAcademic publicationHigh reliability
- [2]South China Morning PostWhat next for He Jiankui, the human gene editor locked in limbo?PressHigh reliability
Last verified: 13 September 2026
